We are a highly-experienced team of drug discovery and development experts focused on making therapies happen that will change the way we age.

christian angermayer
co-founder & chairman of the board
aaron weaver cfa
member of the board of directors
aksana labokha phd
chief executive officer
caleb morgret cfa
chief financial officer
karim allam
chief legal & people officer
stephen helliwell phd
vp discovery biology
matthias steger phd mba
patrick schnider phd
vp medicinal chemistry
prof. manuel serrano phd
co-founder & scientific advisor - rejuveron senescence therapeutics
timothy cash phd
co-founder & chief scientific officer - rejuveron senescence therapeutics
tristan heintz phd
chief scientific officer - rejuveron vascular therapeutics
chien chi hsiao
head of medicinal chemistry - rejuveron vascular therapeutics
marianna feretzaki phd
chief executive officer - rejuveron telomere therapeutics
wareed ahmed phd
senior scientist - rejuveron telomere therapeutics
pierre-antoine mudry bba ms
head, corporate finance and investor relations
kara chatelin
accounting officer in finance
daniele lionetti msc
finance associate
naffi wade
director compliance & strategic projects
lisa caflisch
lab operations manager & bso
csaba budai
it operations manager
malaika schroeder ma
director marketing & communications
dovaine picazo
team assistant
prof. hideyuki okano md phd
member of the scientific advisory board
prof. lee rubin phd
co-founder - rejuveron vascular therapeutics